Differences in the incidence of cirrhosis-associated complications between MASLD, MetALD and ALD among patients with decompensated liver cirrhosis
Saved in:
| Main Authors: | Laura Buttler, Anja Tiede, Marie Griemsmann, Hannah Rieland, Jim B. Mauz, Heiner Wedemeyer, Markus Cornberg, Tammo L. Tergast, Katharina L. Hupa-Breier, Benjamin Maasoumy |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12200844/?tool=EBI |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Differences in the incidence of cirrhosis-associated complications between MASLD, MetALD and ALD among patients with decompensated liver cirrhosis.
by: Laura Buttler, et al.
Published: (2025-01-01) -
MetALD: Clinical aspects, pathophysiology and treatmentKeypoints
by: Jordi Gratacós-Ginès, et al.
Published: (2025-02-01) -
Clinical characteristics of MASLD/MetALD/MAFLD/NAFLD and the relative risk analysis on metabolic disorders
by: Hong-ye Peng, et al.
Published: (2025-05-01) -
Current burden of MASLD, MetALD, and hepatic fibrosis among US adults with prediabetes and diabetes, 2017–2023
by: Donghee Kim, et al.
Published: (2025-07-01) -
High-Sensitivity C-Reactive Protein Levels in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Metabolic Alcohol-Associated Liver Disease (MetALD), and Alcoholic Liver Disease (ALD) with Metabolic Dysfunction
by: Seong-Uk Baek, et al.
Published: (2024-11-01)